TUBA1C and central nervous system cancer: The results of cell biology assays demonstrated that knockdown of MYBL2 or TUBA1C markedly inhibited the proliferation (Figure 9B-E, Figure 10B-E); and migration of glioma cells (Figure 9F-I, Figure 10F-I).